Tag: DPX-E7

April 18, 2017

Immunovaccine Begins Dosing on Clinical Trial

Immunovaccine announced the dosing of the first patient for their investigational cancer vaccine clinical study.
March 31, 2017

Immunovaccine Posts Financial Results For 2016

Immunovaccine (TSX:IMV, OTCQX:IMMVF) announced its financial and operational results for 2016.